Bakhshi S, Arya L S
Department of Pediatrics, Division of Hematology Oncology, All India Institute of Medical Sciences, New Delhi 110 029.
J Assoc Physicians India. 2003 Aug;51:796-800.
Disseminated intravascular coagulation (DIC) involves activation of clotting as well as fibrinolytic pathways. Thrombosis from thrombin release results in end-organ damage, whereas consumption of coagulation factors results in bleeding. Sepsis is the commonest cause of DIC. The consumption of antithrombin in sepsis abrogates its anti-inflammatory role and so its low level is a poor prognostic marker in sepsis. The increased release of plasminogen activator inhibitor-1 (PAI-1) as seen in sepsis decreases fibrinolysis and promotes increased microvascular thrombosis. Here, we discuss the role of inhibitors of coagulation, cytokines, kinins, complement and vasoactive peptides in DIC.
弥散性血管内凝血(DIC)涉及凝血和纤溶途径的激活。凝血酶释放导致的血栓形成会造成终末器官损伤,而凝血因子的消耗则会导致出血。脓毒症是DIC最常见的病因。脓毒症中抗凝血酶的消耗消除了其抗炎作用,因此其低水平是脓毒症预后不良的标志物。脓毒症中纤溶酶原激活物抑制剂-1(PAI-1)释放增加,会降低纤维蛋白溶解并促进微血管血栓形成增加。在此,我们讨论凝血抑制剂、细胞因子、激肽、补体和血管活性肽在DIC中的作用。